Franklin Templeton to move SAT
The Hindu
Franklin Templeton Asset Management (India) said it strongly disagreed with the findings of SEBI’s order in the case of winding up of 6 debt schemes in 2020 and has decided to challenge the direction
Franklin Templeton Asset Management (India) said it strongly disagreed with the findings of SEBI’s order in the case of winding up of 6 debt schemes in 2020 and has decided to challenge the direction in Securities Appellate Tribunal (SAT). SEBI barred the entity from unveiling any new debt scheme for two years and imposed ₹5-crore penalty for violating norms. Also, it has been asked to refund investment management and advisory fees of over ₹512 crore.
The rupee gains 12 paise to 89.51 against the U.S. dollar, buoyed by RBI's liquidity support.
In a recent conversation with Dwarak Rajagopal, Head of AI Research at Snowflake, what stood out was not optimism or scepticism, but maturity.
Explore how India's export landscape is increasingly dominated by a few states, revealing regional disparities and structural challenges.
RBI announces ₹2.90 lakh crore liquidity measures to stabilize markets and address dollar liquidity concerns.
Sensex drops 42 points after two-day rally as IT shares face profit-taking amidst mixed global market cues.
Cholamandalam Investment dismisses Cobrapost's misgovernance allegations as baseless, reaffirming commitment to compliance and transparency.
Gold and silver prices surge to record highs as investors seek safe havens amid geopolitical tensions and rate-cut expectations.
Stock markets decline after two days of gains, with subdued trading expected amid a holiday-shortened week.
Rupee dips to 89.73 against the dollar as Sensex and Nifty also decline amid FII outflows and weak market conditions.
Mercedes-Benz settles multistate emissions allegations for $149.6 million, addressing illegal devices in over 211,000 vehicles.
U.S. approves Wegovy pill for weight loss, expanding access to obesity treatment with a convenient daily oral option.
RBI Bulletin highlights resilient economic activity in India, driven by robust demand, despite challenges in external trade and inflation.
Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing readiness in India.